DISTINCT TOLERANCE PATHWAYS IN SENSITIZED ALLOGRAFT RECIPIENTS AFTER SELECTIVE BLOCKADE OF ACTIVATION SIGNAL 1 OR SIGNAL 21-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DISTINCT TOLERANCE PATHWAYS IN SENSITIZED ALLOGRAFT RECIPIENTS AFTER SELECTIVE BLOCKADE OF ACTIVATION SIGNAL 1 OR SIGNAL 21

Published:1999-07 Issue:2 Volume:68 Page:288-293
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Onodera Kazuhiko,Chandraker Anil,Volk Hans-Dieter,Ritter Thomas,Lehmann Manfred,Kato Hirohisa,Sayegh Mohamed H.,Kupiec-Weglinski Jerzy W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference22 articles.

1. CYCLOSPORINE AND ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY THERAPY SUPPRESS ACCELERATED REJECTION OF RAT CARDIAC ALLOGRAFTS THROUGH DIFFERENT EFFECTOR MECHANISMS

2. DIFFERENTIAL ROLE OF CD4+ CELLS IN THE SENSITIZATION AND EFFECTOR PHASES OF ACCELERATED GRAFT REJECTION

3. ABROGATION BY RAPAMYCIN OF ACCELERATED REJECTION IN SENSITIZED RATS BY INHIBITION OF ALLOANTIBODY RESPONSES AND SELECTIVE SUPPRESSION OF INTRAGRAFT MONONUCLEAR AND ENDOTHELIAL CELL ACTIVATION, CYTOKINE PRODUCTION, AND CELL ADHESION1,2

4. α/β-T CELL RECEPTOR-DIRECTED THERAPY IN RAT CARDIAC ALLOGRAFT RECIPIENTS

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of Tolerance Induction by Hematopoietic Chimerism: The Immune Perspective;Stem Cells Translational Medicine;2017-01-03

2. Induction of antigen specific CD4+CD25+Foxp3+T regulatory cells from naïve natural thymic derived T regulatory cells;International Immunopharmacology;2015-10

3. Inhibition of Arterial Allograft Intimal Hyperplasia Using Recipient Dendritic Cells Pretreated with B7 Antisense Peptide;Clinical and Developmental Immunology;2012

4. Biological therapy of bone defects: the immunology of bone allo-transplantation;Expert Opinion on Biological Therapy;2010-04-23

5. Cold Ischemia Does Not Interfere With Tolerance Induction;Transplantation;2009-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3